Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.6B | 5.4B | 5.9B | 5.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.1B | 1.8B | 2.7B | 2.6B |
| Tax provision | 604M | 542M | 724M | 732M |
| Net income | 1.5B | 1.2B | 1.9B | 1.8B |
| Basic EPS | 0.5 | 0.4 | 0.6 | — |
| Diluted EPS | 0.5 | 0.4 | 0.6 | — |
| Basic average shares | 3.1B | 3.1B | 3.2B | — |
| Diluted average shares | 3.1B | 3.1B | 3.2B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -65M | -74M | -65M | -57M |
| Preferred stock dividends | — | — | — | — |